Alembic Pharma gets USFDA nod for Parkinson#39;s treatment drug

The approval from the United States Food and Drug Administration (USFDA) is for the company#39;s abbreviated new drug application (ANDA) for Pramipexole Dihydrochloride extended-release tablets, in the strengths of 0.375 mg, 0.75 mg, 1.5 mg, 2.25 mg, 3 mg, 3.75 mg, and 4.5 mg, Alembic Pharmaceuticals said in a filing to BSE.

from Moneycontrol Business News http://bit.ly/2CLidvZ